Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health
Bull Case

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

• Cardinal Health, Inc. recently reported earnings per share of $2.91 for the quarter ended August 11, 2026, which significantly exceeded the analyst consensus estimate of $2.42, demonstrating strong profitability and operational efficiency that can drive shareholder value.
• The stock is currently trading at $239.25, which is below the consensus price target of $266.56 set by sixteen analysts who have rated the stock with a Buy rating, suggesting there is still significant upside potential for investors entering the position now.
• Cardinal Health, Inc. has raised its full-year 2027 earnings per share guidance to a range of $12.40 to $12.60, which is above the previous consensus estimate of $12.05, indicating management confidence in continued growth and strong future performance.
• Institutional investors are showing strong conviction in the company, with Wellington Management Group LLP increasing its holdings by 247.5% in the second quarter and BlackRock Inc. acquiring a new stake worth over $6.2 billion, signaling that large funds view the stock as a core holding.
• The company maintains a low beta of 0.49, meaning its stock price tends to be less volatile than the overall market, which can provide a defensive characteristic for investors seeking stability in their portfolio during periods of market uncertainty.